The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0775
Bid: 0.075
Ask: 0.08
Change: -0.0055 (-6.63%)
Spread: 0.005 (6.667%)
Open: 0.083
High: 0.083
Low: 0.0775
Prev. Close: 0.083
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 May 2020 07:00

RNS Number : 3191N
CAP-XX Limited
19 May 2020
 

 

 

 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

19 May 2020

 

CAP-XX Limited

("CAP-XX" the "Company")

 

Trading Update

Update on transfer of manufacturing assets

 

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, today announces a trading update in respect of the financial year ending 30 June 2020 and its recent activities.

 

Revenue for the year ending 30 June 2020 is expected to be around 15% higher than the prior year at approximately A$3.7m (2019: A$3.2m). Revenue in the second half of the financial year has been affected by a delay in supercapacitor shipments, as some customers have delayed delivery dates and due to the impact of COVID-19 on CAP-XX's manufacturing output. Adjusted EBITDA for the year ending 30 June 2020 is expected to be a loss of approximately A$2.0m (2019: a loss of A$1.6m). The increase in the expected EBITDA loss is due to the factors referred to above and legal costs from the Ioxus patent infringement case.

 

The current sales order book for the underlying CAP-XX product lines is greater than twice the level at the same point last year. This increase has been driven by the medical, security and telecommunication market segments.

 

As previously announced, CAP-XX has undertaken a strategy of pursuing several competitor supercapacitor organisations in potential patent infringement cases. In relation to this strategy, the Board remains confident of winning a patent infringement case against Ioxus, Inc ("Ioxus"), but is now not forecasting any significant financial return from this action, as the Board understands that Ioxus has sold all of its assets.

 

Installation of the first shipment of the former Murata manufacturing assets is underway at CAP-XX's new Sydney manufacturing facility and the second and third shipments have left Murata and are in transit. Due to the COVID-19 pandemic, international shipping schedules have been greatly reduced and this has led to delays in the third and final shipment leaving Kobe port in Japan. Overall, the Board now believes that the completion of the transfer of Murata's manufacturing assets will be delayed by up to three months. The Board believes that the Company will be able to absorb the anticipated additional costs of this delay within its cash resources.

 

CAP-XX has now vacated its old premises at Lane Cove and has moved all equipment to the new manufacturing facility at Seven Hills, Sydney. The Company has also secured the necessary construction materials, despite difficult supply lines and the COVID-19 related work restrictions put in place by Government. The Company has made arrangements for remote engineering support to assist with the installation and commissioning of the former Murata production line while personal travel restrictions between Japan and Australia remain in place.

 

As part of the project to transfer the former Murata manufacturing assets, CAP-XX has acquired the outstanding finished stock of Murata supercapacitors, which was manufactured to facilitate the transition of Murata's customers to CAP-XX. Direct product sales from CAP-XX of the expanded product range have now commenced, supported by the launch of a new CAP-XX website. Overall, the Company has made good progress in engaging with all of Murata's customers and the Board is confident that the successful retention of these customers will happen largely as expected. However, many of these new customers are reporting high current levels of inventory.

 

Cash as of 8 May 2020 was A$4.4m. The Board also expects to receive a payment from the Australian Taxation Office of A$3.3m in the fourth calendar quarter of 2020. The Board is confident that the Company will have sufficient cash to complete the integration of the ex-Murata customers and the former Murata manufacturing assets, which the Board believes will result in a significant uplift in revenues and ultimately positive cashflow from operations in due course.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUUAAUPUUAB
Date   Source Headline
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.